Author Question: How do increasing returns to scale affect the shape of the long-run average cost curve? What will ... (Read 115 times)

fbq8i

  • Hero Member
  • *****
  • Posts: 527
How do increasing returns to scale affect the shape of the long-run average cost curve?
 
  What will be an ideal response?

Question 2

If marginal costs are constant what will the average variable cost curve look like? What about the average total cost curve?
 
  What will be an ideal response?



zacnyjessica

  • Sr. Member
  • ****
  • Posts: 345
Answer to Question 1

When the firm faces increasing returns to scale, average costs per unit produced fall as the firm's scale of production rises. Thus, the long-run average cost curve would be downward sloping.

Answer to Question 2

The average variable cost curve will coincide with the average variable cost. The average total cost curve will slope downward but will not be U-shaped.



Related Topics

Need homework help now?

Ask unlimited questions for free

Ask a Question
 

Did you know?

The first monoclonal antibodies were made exclusively from mouse cells. Some are now fully human, which means they are likely to be safer and may be more effective than older monoclonal antibodies.

Did you know?

Vital signs (blood pressure, temperature, pulse rate, respiration rate) should be taken before any drug administration. Patients should be informed not to use tobacco or caffeine at least 30 minutes before their appointment.

Did you know?

Serum cholesterol testing in adults is recommended every 1 to 5 years. People with diabetes and a family history of high cholesterol should be tested even more frequently.

Did you know?

There are major differences in the metabolism of morphine and the illegal drug heroin. Morphine mostly produces its CNS effects through m-receptors, and at k- and d-receptors. Heroin has a slight affinity for opiate receptors. Most of its actions are due to metabolism to active metabolites (6-acetylmorphine, morphine, and morphine-6-glucuronide).

Did you know?

HIV testing reach is still limited. An estimated 40% of people with HIV (more than 14 million) remain undiagnosed and do not know their infection status.

For a complete list of videos, visit our video library